Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Security

CYPH · CYPHERPUNK TECHNOLOGIES INC.

CYPHNASDAQCommon stockCurrentCIK 1509745Updated Sep 26, 2026

Company: CYPHERPUNK TECHNOLOGIES INC. →

Name history
LEAP THERAPEUTICS, INC. · through Nov 12, 2025Dekkun Corp · through Jan 7, 2011

CYPH price & chart

Provider market data

Loading TradingView…

NASDAQ:CYPH on TradingView ↗

TradingView · Data may be delayed

About the company

Cypherpunk Technologies is a privacy technology company. The Company’s mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through three primary strategies: mining Zcash through Cypherpunk Mining; accumulating Zcash through open market purchases; and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, the Company is developing novel therapies for patients with cancer by continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov.

8-K · 2026-09-22 · 0001104659-26-109463

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income4,822,000USD · FY 2025
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

Operating income-41,067,000USD · FY 2025
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

Diluted EPS0.07USD per share · FY 2025
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD163,182,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

49,124,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

72,825,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

70,353,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Property, Plant and EquipmentUSD0
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

0
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

5,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

20,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD14,035,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

47,249,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

70,643,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

65,500,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Assets, CurrentUSD162,081,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

48,039,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

71,597,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

67,950,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD40,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

86,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

183,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

351,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD38,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

262,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

257,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

669,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Other Assets, NoncurrentUSD———30,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD9,676,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

—12,684,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

11,487,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD84,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

38,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

26,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

99,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Additional Paid in CapitalUSD616,216,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

502,501,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

459,591,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

376,807,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-462,549,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

-467,371,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

-399,582,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

-318,168,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-95,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

-120,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

106,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

128,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD153,506,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

35,048,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

60,141,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

58,866,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Liabilities and EquityUSD163,182,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

49,124,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

72,825,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

70,353,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD4,558,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

14,076,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

12,684,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

11,225,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Operating Lease, Liability, CurrentUSD38,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

266,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

262,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

416,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Accounts Payable, CurrentUSD1,981,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

4,743,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

6,465,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

5,657,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD———262,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Deferred Income Tax Liabilities, NetUSD5,118,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

———
Additional Financial Items
Accrued Liabilities, CurrentUSD2,067,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

8,536,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

5,957,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

5,152,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Deferred Tax Liabilities, NetUSD5,118,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

———

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD4,822,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-67,555,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-81,414,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-54,596,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD4,899,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

5,504,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

5,128,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

5,180,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD5,118,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

——147,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD-43,902,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-60,299,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-43,753,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-49,044,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-97,000,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

—48,969,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

—
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD107,649,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

37,184,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-30,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-210,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD-33,214,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-23,394,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

5,143,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-49,416,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD14,035,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

As of 2025-12-31

47,249,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

As of 2024-12-31

70,643,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

As of 2023-12-31

65,500,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

As of 2022-12-31

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD39,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-279,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-43,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-162,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Additional Financial Items
AmortizationUSD———0
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, ExpenseUSD———5,180,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

DepreciationUSD0
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

5,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

15,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

16,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), before TaxUSD5,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-42,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-13,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-608,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD10,870,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

12,846,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

13,807,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

11,798,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD5,255,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

585,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

—147,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

InterestExpenseNonoperatingUSD24,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD4,822,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-67,555,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-81,414,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-54,596,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD4,822,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-67,789,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-81,414,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-54,596,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Operating ExpensesUSD41,067,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

70,057,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

87,041,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

56,763,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD———451,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Payments for Repurchase of WarrantsUSD——29,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

—
Proceeds from Stock Options ExercisedUSD16,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

92,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD-41,067,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-70,057,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-87,041,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-56,763,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD10,077,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-66,970,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-81,414,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-54,449,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD5,255,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

585,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

—147,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD4,822,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-67,555,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-81,414,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-54,596,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share0.07
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-1.81
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-3.98
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-0.48
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share0.07
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-1.81
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-3.98
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-0.48
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares66,140,346
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

37,550,677
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

20,445,109
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

113,239,092
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares70,672,358
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

37,550,677
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

20,445,109
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

113,239,092
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD24,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

———
Additional Financial Items
Current Income Tax Expense (Benefit)USD137,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

585,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

——
Foreign Currency Transaction Gain (Loss), before TaxUSD5,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-42,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-13,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-608,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD10,870,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

12,846,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

13,807,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

11,798,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD9,639,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-69,475,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-80,895,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-50,325,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Interest ExpenseUSD———54,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD4,822,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

-67,789,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

-81,414,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

-54,596,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Operating ExpensesUSD41,067,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

70,057,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

87,041,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

56,763,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD———451,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD25,670,000
Source

10-K · 2026-03-16 · 0001104659-26-028566

2025-01-01 to 2025-12-31

57,211,000
Source

10-K · 2025-03-26 · 0001410578-25-000454

2024-01-01 to 2024-12-31

73,234,000
Source

10-K · 2024-03-18 · 0001410578-24-000218

2023-01-01 to 2023-12-31

44,965,000
Source

10-K · 2023-03-24 · 0001104659-23-036239

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

tm2625876d1_ex99-1.htm · 8-K · 2026-09-22

Exhibit 99.1 Cypherpunk Technologies Appoints Amanda Fabiano to Board of Directors Veteran mining executive brings operational depth from Nakamoto, TeraWulf, Galaxy, and Fidelity as Cypherpunk launches 4.2 GSol/s Zcash mining fleet Cypherpunk Mining generated 3,023.13 ZEC in first weeks of operation; Added to Treasury Cambridge, Mass., - September 22, 2026 - Cypherpunk Technologies Inc. (Nasdaq: CYPH) (“Cypherpunk”), a privacy technology company, today announced the appointment of Amanda Fab…

8-K · 2026-09-22 · 0001104659-26-109463

Read attachment ↗
tm2623453d1_ex4-1.htm · 8-K · 2026-08-18

EX-4.1 3 tm2623453d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ SECURITIES ACT ”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUA…

8-K · 2026-08-18 · 0001104659-26-098120

Read attachment ↗
tm2623453d1_ex99-1.htm · 8-K · 2026-08-18

EX-99.1 5 tm2623453d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cypherpunk Technologies Launches World's Largest Zcash Mining Fleet Equity-based transaction with Winklevoss Capital activates 4.2 GSol/s of live, U.S.-based hashrate; approximately 18% of the Zcash network; Industry veteran Kevin Zhang joins as Head of Mining Cambridge, Mass. - August 18, 2026 - Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk") today announced the launch of Cypherpunk Mining, which is now the largest Zc…

8-K · 2026-08-18 · 0001104659-26-098120

Read attachment ↗
tm2622925d1_ex99-1.htm · 8-K · 2026-08-12

EX-99.1 2 tm2622925d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cypherpunk Technologies Reports Second Quarter 2026 Financial Results Cambridge, Mass. - August 12, 2026 - Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026. "In the second quarter, Cypherpunk built upon the momentum established earlier this year through the disciplined execution of our Zcash digital asset treasury strategy, increasing our treas…

8-K · 2026-08-12 · 0001104659-26-094445

Read attachment ↗
tm2622925d1_ex99-2.htm · 8-K · 2026-08-12

EX-99.2 3 tm2622925d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research · Peer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients · In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapy CAMBRIDGE, Mass., August 12,…

8-K · 2026-08-12 · 0001104659-26-094445

Read attachment ↗
tm2614533d1_ex99-1.htm · 8-K · 2026-05-14

EX-99.1 2 tm2614533d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cypherpunk Technologies Reports First Quarter 2026 Financial Results Cambridge, MA - May 14, 2026 - Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026. "Since the start of 2026, Cypherpunk has advanced the mission to become a leading privacy technology company with a digital asset treasury strategy focused on Zcash by making our first privacy tec…

8-K · 2026-05-14 · 0001104659-26-060686

Read attachment ↗